secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTELLIGENT BIO SOLUTIONS INC. (INBS)
CIK:        0001725430
Form:       8-K
Filed at:   2025-08-15T23:59:59+00:00
Accession:  0001493152-25-012101
Event type: earnings
Sentiment:  positive
Materiality: 0.55
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Intelligent Bio Solutions Q4 revenue up 16% YoY to $844K; progress on FDA 510(k) for U.S. market
--------------------------------------------------------------------------------

- Q4 FY2025 revenue $843,884 (+16% YoY); cartridge sales up 24% YoY.
- Added 115 new accounts in FY2025; active base >450 across 24 countries with 18 distributors.
- FDA 510(k) submission in progress for opiate test system; seeking U.S. clearance beyond Forensic Use Only.
- Operational improvements: multilingual system, HubSpot CRM, new U.S. patent; accounting system upgrade underway.
- Net loss or EPS not disclosed; company reports 'reduced net loss' but no specific figures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225012101/0001493152-25-012101-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1725430/000149315225012101/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-012101

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer